Massimo Colombo

3.5k total citations · 1 hit paper
26 papers, 2.0k citations indexed

About

Massimo Colombo is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Massimo Colombo has authored 26 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 21 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Massimo Colombo's work include Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (16 papers) and Hepatitis B Virus Studies (13 papers). Massimo Colombo is often cited by papers focused on Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (16 papers) and Hepatitis B Virus Studies (13 papers). Massimo Colombo collaborates with scholars based in Italy, United States and Switzerland. Massimo Colombo's co-authors include Dario Conte, Alberto Zanella, G. Sirchia, Daniele Prati, Fulvio Mozzi, Silvano Milani, Emanuela Taioli, Luciana Vianello, F Zanuso and Maria Grazia Rumi and has published in prestigious journals such as Blood, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Massimo Colombo

25 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels

2002 1.1k citations Dario Conte, Massimo Colombo et al. Annals of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Colombo Italy	15	1.6k	1.3k	337	185	160	26	2.0k
Consuelo Soldevila‐Pico United States	22	1.5k 0.9×	1.4k 1.1×	226 0.7×	364 2.0×	94 0.6×	41	2.0k
Luciana Vianello Italy	7	1.1k 0.7×	695 0.6×	309 0.9×	163 0.9×	136 0.8×	9	1.4k
Yoshio Tokumoto Japan	22	1.1k 0.7×	840 0.7×	243 0.7×	219 1.2×	148 0.9×	124	1.6k
Rosa Lombardi Italy	24	1.1k 0.7×	546 0.4×	419 1.2×	207 1.1×	199 1.2×	73	1.5k
V. Canva France	21	1.4k 0.8×	1.2k 0.9×	215 0.6×	144 0.8×	586 3.7×	58	1.8k
Dev Samarasinghe Australia	14	2.0k 1.2×	1.0k 0.8×	706 2.1×	339 1.8×	248 1.6×	22	2.3k
Bart J. Veldt Netherlands	19	2.5k 1.5×	2.4k 1.9×	183 0.5×	208 1.1×	78 0.5×	42	3.0k
Rita Lin Australia	16	1.9k 1.2×	985 0.8×	699 2.1×	296 1.6×	237 1.5×	22	2.2k
F Zanuso Italy	7	1.2k 0.7×	777 0.6×	311 0.9×	131 0.7×	139 0.9×	9	1.4k
Laurentius A. Lesmana Indonesia	19	2.3k 1.4×	2.0k 1.6×	309 0.9×	491 2.7×	172 1.1×	61	2.7k

Countries citing papers authored by Massimo Colombo

Since Specialization

Citations

This map shows the geographic impact of Massimo Colombo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Colombo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Colombo more than expected).

Fields of papers citing papers by Massimo Colombo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Colombo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Colombo. The network helps show where Massimo Colombo may publish in the future.

Co-authorship network of co-authors of Massimo Colombo

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Colombo. A scholar is included among the top collaborators of Massimo Colombo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Colombo. Massimo Colombo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Degasperi, Elisabetta, Roberta D’Ambrosio, Massimo Iavarone, et al.. (2018). Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection. Clinical Gastroenterology and Hepatology. 17(6). 1183–1191.e7. 83 indexed citations

Lampertico, Pietro, G. Grossi, Alessandro Loglio, et al.. (2017). High rates of renal tubular damage in HBV monoinfected patients long-term treated with Tenofovir: a cross-sectional, single center, real-life study in 414 patients. Journal of Hepatology. 66(1). S689–S689. 1 indexed citations

Iurlo, Alessandra, Daniele Cattaneo, Umberto Gianelli, et al.. (2014). Spleen Stiffness Measurement By Transient Elastography As a Predictor of Bone Marrow Fibrosis in Primary Myelofibrosis Patients. Blood. 124(21). 1825–1825. 3 indexed citations

Oliviero, Barbara, Dalila Mele, Elisabetta Degasperi, et al.. (2013). Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection. Journal of Hepatology. 59(1). 38–44. 46 indexed citations

Degasperi, Elisabetta, Mauro Viganò, Alessio Aghemo, Pietro Lampertico, & Massimo Colombo. (2013). PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history. Expert Review of Anti-infective Therapy. 11(5). 459–474. 14 indexed citations

Valenti, Luca, Benedetta Maria Motta, Giorgio Soardo, et al.. (2013). PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma. PLoS ONE. 8(10). e75982–e75982. 48 indexed citations

Lampertico, Pietro, Mauro Viganò, G.G. Di Costanzo, et al.. (2012). Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B. Gut. 62(2). 290–298. 83 indexed citations

Fraquelli, Mirella, Cristina Rigamonti, Giovanni Casazza, et al.. (2010). Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. Journal of Hepatology. 54(4). 621–628. 101 indexed citations

Massironi, Sara, Mirella Fraquelli, Silvia Paggi, et al.. (2008). Chromogranin A levels in chronic liver disease and hepatocellular carcinoma. Digestive and Liver Disease. 41(1). 31–35. 35 indexed citations

10.

Lampertico, Pietro, Mauro Viganò, E. Manenti, et al.. (2007). [57] 3 YEARS OF ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY MINIMIZES THE RISK OF GENOTYPIC RESISTANCE TO ADV IN LAM RESISTANT PATIENTS. Journal of Hepatology. 46. S27–S27. 3 indexed citations

11.

Iavarone, Massimo, Pietro Lampertico, Francesca Iannuzzi, et al.. (2006). Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma. Journal of Viral Hepatitis. 14(2). 133–139. 42 indexed citations

12.

Caccamo, L., R. Romeo, G. Rossi, et al.. (2005). No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants. Transplant International. 18(2). 186–192. 9 indexed citations

13.

Marzano, Alfredo, Pietro Lampertico, Vincenzo Mazzaferro, et al.. (2005). Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants. Liver Transplantation. 11(5). 532–538. 61 indexed citations

14.

Lampertico, Pietro, Mauro Viganò, R. Romeo, et al.. (2002). Long-term outcome of hepatitis B in lamivudine-resistant cirrhotic patients. Journal of Hepatology. 36. 115–115. 1 indexed citations

15.

Colombo, Massimo. (1996). Treatment of "problematic" hepatitis C patients.. PubMed. 28(7). 393–5.

16.

Colombo, Massimo. (1996). The natural history of hepatitis C. Baillière s Clinical Gastroenterology. 10(2). 275–288. 44 indexed citations

17.

Lampertico, Pietro, Aldo Manzin, Maria Grazia Rumi, et al.. (1995). Hepatitis B virus precore mutants in HBeAg carriers with chronic hepatitis treated with interferon. Journal of Viral Hepatitis. 2(5). 251–256. 13 indexed citations

18.

Colombo, Massimo. (1993). Hepatocellular Carcinoma in Cirrhotics. Seminars in Liver Disease. 9(4). 374–383. 32 indexed citations

19.

Rumi, Maria Grazia, et al.. (1990). High Prevalence of Antibody to Hepatitis C Virus in Multitransfused Hemophiliacs with Normal Transaminase Levels. Annals of Internal Medicine. 112(5). 379–380. 115 indexed citations

20.

Colombo, Massimo, Roberto de Franchis, Maurizio Tommasini, Angelo Sangiovanni, & N Dioguardi. (1989). β-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial. Hepatology. 9(3). 433–438. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact